Biodosimetry on small blood volume using gene expression assay

Muriel Brengues, Brigitte Paap, Michael Bittner, Sally Amundson, Bruce Seligmann, Ronald Korn, Ralf Lenigk, Frederic Zenhausern

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

This paper reports the development of a biodosimetry device suitable for rapidly measuring expression levels of a low-density gene set that can define radiation exposure, dose and injury in a public health emergency. The platform comprises a set of 14 genes selected on the basis of their abundance and differential expression level in response to radiation from an expression profiling series measuring 41,000 transcripts. Gene expression is analyzed through direct signal amplification using a quantitative Nuclease Protection Assay (qNPA). This assay can be configured as either a high-throughput microplate assay or as a handheld detection device for individual point-of-care assays. Recently, we were able to successfully develop the qNPA platform to measure gene expression levels directly from human whole blood samples. The assay can be performed with volumes as small as 30 μL of whole blood, which is compatible with collection from a fingerstick. We analyzed in vitro irradiated blood samples with qNPA. The results revealed statistically significant discrimination between irradiated and non-irradiated samples. These results indicate that the qNPA platform combined with a gene profile based on a small number of genes is a valid test to measure biological radiation exposure. The scalability characteristics of the assay make it appropriate for population triage. This biodosimetry platform could also be used for personalized monitoring of radiotherapy treatments received by patients.

Original languageEnglish (US)
Pages (from-to)179-185
Number of pages7
JournalHealth Physics
Volume98
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Nuclease Protection Assays
Blood Volume
Gene Expression
Genes
Point-of-Care Systems
Equipment and Supplies
Radiation Injuries
Triage
Emergencies
Radiotherapy
Public Health
Radiation
Population

Keywords

  • Accidents
  • Blood
  • Dosimetry
  • Handling
  • Radiological terrorism

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis
  • Epidemiology

Cite this

Brengues, M., Paap, B., Bittner, M., Amundson, S., Seligmann, B., Korn, R., ... Zenhausern, F. (2010). Biodosimetry on small blood volume using gene expression assay. Health Physics, 98(2), 179-185. https://doi.org/10.1097/01.HP.0000346706.44253.5c

Biodosimetry on small blood volume using gene expression assay. / Brengues, Muriel; Paap, Brigitte; Bittner, Michael; Amundson, Sally; Seligmann, Bruce; Korn, Ronald; Lenigk, Ralf; Zenhausern, Frederic.

In: Health Physics, Vol. 98, No. 2, 02.2010, p. 179-185.

Research output: Contribution to journalArticle

Brengues, M, Paap, B, Bittner, M, Amundson, S, Seligmann, B, Korn, R, Lenigk, R & Zenhausern, F 2010, 'Biodosimetry on small blood volume using gene expression assay', Health Physics, vol. 98, no. 2, pp. 179-185. https://doi.org/10.1097/01.HP.0000346706.44253.5c
Brengues M, Paap B, Bittner M, Amundson S, Seligmann B, Korn R et al. Biodosimetry on small blood volume using gene expression assay. Health Physics. 2010 Feb;98(2):179-185. https://doi.org/10.1097/01.HP.0000346706.44253.5c
Brengues, Muriel ; Paap, Brigitte ; Bittner, Michael ; Amundson, Sally ; Seligmann, Bruce ; Korn, Ronald ; Lenigk, Ralf ; Zenhausern, Frederic. / Biodosimetry on small blood volume using gene expression assay. In: Health Physics. 2010 ; Vol. 98, No. 2. pp. 179-185.
@article{7daa4e4bab4a437ba8b61ca6ff92aa24,
title = "Biodosimetry on small blood volume using gene expression assay",
abstract = "This paper reports the development of a biodosimetry device suitable for rapidly measuring expression levels of a low-density gene set that can define radiation exposure, dose and injury in a public health emergency. The platform comprises a set of 14 genes selected on the basis of their abundance and differential expression level in response to radiation from an expression profiling series measuring 41,000 transcripts. Gene expression is analyzed through direct signal amplification using a quantitative Nuclease Protection Assay (qNPA). This assay can be configured as either a high-throughput microplate assay or as a handheld detection device for individual point-of-care assays. Recently, we were able to successfully develop the qNPA platform to measure gene expression levels directly from human whole blood samples. The assay can be performed with volumes as small as 30 μL of whole blood, which is compatible with collection from a fingerstick. We analyzed in vitro irradiated blood samples with qNPA. The results revealed statistically significant discrimination between irradiated and non-irradiated samples. These results indicate that the qNPA platform combined with a gene profile based on a small number of genes is a valid test to measure biological radiation exposure. The scalability characteristics of the assay make it appropriate for population triage. This biodosimetry platform could also be used for personalized monitoring of radiotherapy treatments received by patients.",
keywords = "Accidents, Blood, Dosimetry, Handling, Radiological terrorism",
author = "Muriel Brengues and Brigitte Paap and Michael Bittner and Sally Amundson and Bruce Seligmann and Ronald Korn and Ralf Lenigk and Frederic Zenhausern",
year = "2010",
month = "2",
doi = "10.1097/01.HP.0000346706.44253.5c",
language = "English (US)",
volume = "98",
pages = "179--185",
journal = "Health Physics",
issn = "0017-9078",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Biodosimetry on small blood volume using gene expression assay

AU - Brengues, Muriel

AU - Paap, Brigitte

AU - Bittner, Michael

AU - Amundson, Sally

AU - Seligmann, Bruce

AU - Korn, Ronald

AU - Lenigk, Ralf

AU - Zenhausern, Frederic

PY - 2010/2

Y1 - 2010/2

N2 - This paper reports the development of a biodosimetry device suitable for rapidly measuring expression levels of a low-density gene set that can define radiation exposure, dose and injury in a public health emergency. The platform comprises a set of 14 genes selected on the basis of their abundance and differential expression level in response to radiation from an expression profiling series measuring 41,000 transcripts. Gene expression is analyzed through direct signal amplification using a quantitative Nuclease Protection Assay (qNPA). This assay can be configured as either a high-throughput microplate assay or as a handheld detection device for individual point-of-care assays. Recently, we were able to successfully develop the qNPA platform to measure gene expression levels directly from human whole blood samples. The assay can be performed with volumes as small as 30 μL of whole blood, which is compatible with collection from a fingerstick. We analyzed in vitro irradiated blood samples with qNPA. The results revealed statistically significant discrimination between irradiated and non-irradiated samples. These results indicate that the qNPA platform combined with a gene profile based on a small number of genes is a valid test to measure biological radiation exposure. The scalability characteristics of the assay make it appropriate for population triage. This biodosimetry platform could also be used for personalized monitoring of radiotherapy treatments received by patients.

AB - This paper reports the development of a biodosimetry device suitable for rapidly measuring expression levels of a low-density gene set that can define radiation exposure, dose and injury in a public health emergency. The platform comprises a set of 14 genes selected on the basis of their abundance and differential expression level in response to radiation from an expression profiling series measuring 41,000 transcripts. Gene expression is analyzed through direct signal amplification using a quantitative Nuclease Protection Assay (qNPA). This assay can be configured as either a high-throughput microplate assay or as a handheld detection device for individual point-of-care assays. Recently, we were able to successfully develop the qNPA platform to measure gene expression levels directly from human whole blood samples. The assay can be performed with volumes as small as 30 μL of whole blood, which is compatible with collection from a fingerstick. We analyzed in vitro irradiated blood samples with qNPA. The results revealed statistically significant discrimination between irradiated and non-irradiated samples. These results indicate that the qNPA platform combined with a gene profile based on a small number of genes is a valid test to measure biological radiation exposure. The scalability characteristics of the assay make it appropriate for population triage. This biodosimetry platform could also be used for personalized monitoring of radiotherapy treatments received by patients.

KW - Accidents

KW - Blood

KW - Dosimetry

KW - Handling

KW - Radiological terrorism

UR - http://www.scopus.com/inward/record.url?scp=75649110801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649110801&partnerID=8YFLogxK

U2 - 10.1097/01.HP.0000346706.44253.5c

DO - 10.1097/01.HP.0000346706.44253.5c

M3 - Article

C2 - 20065681

AN - SCOPUS:75649110801

VL - 98

SP - 179

EP - 185

JO - Health Physics

JF - Health Physics

SN - 0017-9078

IS - 2

ER -